Causal association of calcific aortic valve stenosis and atrial fibrillation: a Mendelian randomization study

Chen Chai1, Shoupeng Li2, Lin Chen3

  • 1Emergency Center, Hubei Clinical Research Center for Emergency and Resuscitation, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, 430071, China.

Scientific Reports
|November 21, 2023
PubMed

Insights

Calcific aortic valve stenosis (CAVS) significantly increases the risk of atrial fibrillation (AF). This genetic study provides strong evidence for a causal link between CAVS and AF, supporting targeted interventions.

Area of Science:

  • Cardiology
  • Genetics
  • Epidemiology

Background:

  • Observational studies suggest a link between calcific aortic valve stenosis (CAVS) and atrial fibrillation (AF).
  • The causal nature of this association remains undetermined.
  • Understanding this relationship is crucial for cardiovascular disease management.

Purpose of the Study:

  • To investigate the potential causal relationship between CAVS and AF using Mendelian randomization (MR).
  • To assess whether genetic predisposition to CAVS influences the risk of developing AF.

Main Methods:

  • Utilized genome-wide association study (GWAS) summary data for CAVS in a European population.
  • Employed the inverse variance weighted (IVW) method for primary causal inference.
  • Conducted sensitivity analyses using MR-Egger and weighted median approaches to ensure result robustness.
  • Identified nineteen independent genetic single nucleotide polymorphisms (SNPs) associated with CAVS.

Main Results:

  • Genetically predicted CAVS showed a significant association with an increased risk of AF (OR: 1.105; 95% CI: 1.072-1.139; p = 8.60E-11).
  • Sensitivity analyses confirmed the robustness of the primary findings.
  • The MR design effectively minimized confounding factors and reverse causality bias.

Conclusions:

  • This study provides robust genetic evidence supporting a causal relationship between CAVS and an increased risk of AF.
  • Findings suggest that CAVS is a significant risk factor for AF.
  • These results may inform future therapeutic strategies for patients with CAVS.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...